The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration: Results from the Randomized Phase 2 Ladder Clinical Trial - ScienceDirect
Breaking the Burden: A New Way to Deliver Anti-VEGF
Figure of the port delivery system (PDS) implant with dimensions of... | Download Scientific Diagram
Pharmaceutics | Free Full-Text | Ocular Drug Delivery to the Retina: Current Innovations and Future Perspectives
The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration: Results from the Randomized Phase 2 Ladder Clinical Trial - ScienceDirect
Ranibizumab port delivery system: a clinical perspective | BMJ Open Ophthalmology
Implant May Replace Monthly Injections for Wet AMD
In-vitro characterization of ranibizumab release from the Port Delivery System - ScienceDirect
Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
The Port Delivery System with ranibizumab: a new paradigm for long-acting retinal drug delivery
Retinal Physician - The Port Delivery System With Ranibizumab
The promise of PDS in real-world practice
Retina Global - Vision outcomes using a port delivery system proved equivalent to ranibizumab injections and showed a positive benefit profile. #PDS #nAMD #antiVEGF http://bit.ly/3nqW8aS | Facebook
Company Name
Port Delivery System Delivers Medication Via an Implant
A custom virtual reality training solution for ophthalmologic surgical clinical trials | Advances in Simulation | Full Text
FDA Approves Genentech's Port Delivery System, Susvimo, a First-of-Its-Kind Therapeutic Approach for Wet AMD
Evaluation of Port Delivery System with ranibizumab for the treatment of neovascular age-related macular degeneration | Therapeutic Delivery
Investigators: Ranibizumab Port Delivery System Durable, Effective - Ophthalmology Advisor
The Port Delivery System with ranibizumab—journey of mitigating vitreous hemorrhage | Eye
Port Delivery System Delivers Medication Via an Implant
La FDA acepta la solicitud de administración de ranibizumab a través del sistema Port Delivery System (PDS) para para el tratamiento de la DMAE neovascular - Asociación Mácula Retina
Evaluation of Port Delivery System with ranibizumab for the treatment of neovascular age-related macular degeneration | Therapeutic Delivery
Refill-Exchange Procedure of the Port Delivery System With Ranibizumab: Overview and Clinical Trial Experience | Ophthalmic Surgery, Lasers and Imaging Retina
Retinal Physician - Tips and Tricks for the Port Delivery System
